Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
COPDRespiratory Tract DiseasePulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveLung Diseases
Interventions
OTHER

Wellinks

"30-day post-discharge period: virtual respiratory therapist sessions twice per week with synchronous virtual pulmonary rehabilitation and educational materials; at-home use of connected spirometer and pulse oximeter; at-home use of mobile app.~12-week intensive period: virtual health coaching sessions once every two weeks; asynchronous virtual pulmonary rehabilitation program; ongoing access to connected devices (spirometer and pulse oximeter) and mobile app."

Trial Locations (1)

06102

RECRUITING

Hartford Hospital, Hartford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hartford HealthCare

OTHER

lead

Convexity Scientific Inc

INDUSTRY

NCT05330507 - Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions | Biotech Hunter | Biotech Hunter